ACP
WHWK
Acuta Capital Partners’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.38M | Hold |
3,410,402
| – | – | 8.9% | 3 |
|
|
2025
Q1 | $6.07M | Buy |
3,410,402
+1,561,000
| +84% | +$2.78M | 7.04% | 4 |
|
|
2024
Q4 | $5.83M | Hold |
1,849,402
| – | – | 5.87% | 6 |
|
|
2024
Q3 | $3.81M | Hold |
1,849,402
| – | – | 3.09% | 13 |
|
|
2024
Q2 | $2.7M | Hold |
1,849,402
| – | – | 2.27% | 17 |
|
|
2024
Q1 | $4.33M | Hold |
1,849,402
| – | – | 2.81% | 15 |
|
|
2023
Q4 | $3.74M | Hold |
1,849,402
| – | – | 2.1% | 20 |
|
|
2023
Q3 | $8.95M | Hold |
1,849,402
| – | – | 6% | 3 |
|
|
2023
Q2 | $12.6M | Hold |
1,849,402
| – | – | 8.57% | 2 |
|
|
2023
Q1 | $13.4M | Hold |
1,849,402
| – | – | 9.86% | 2 |
|
|
2022
Q4 | $19.6M | Hold |
1,849,402
| – | – | 12.08% | 1 |
|
|
2022
Q3 | $26.1M | Buy |
1,849,402
+320,000
| +21% | +$4.52M | 11.25% | 2 |
|
|
2022
Q2 | $18.8M | Hold |
1,529,402
| – | – | 10.5% | 2 |
|
|
2022
Q1 | $26M | Hold |
1,529,402
| – | – | 12.13% | 2 |
|
|
2021
Q4 | $36.9M | Hold |
1,529,402
| – | – | 15.53% | 1 |
|
|
2021
Q3 | $44.9M | Buy |
+1,529,402
| New | +$44.9M | 15.85% | 1 |
|